You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study

Alerts

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address